| JIANGSU HENGRUI PHARMACEUTICALS |
| China |
| Gesundheit |
| CNE100006XS6 / A41984 |
| 0BO (Frankfurt) |
| FRA:0BO, ETR:0BO, 0BO:GR |
| - |
| https://www.hengrui.com/ |
|
Jiangsu Hengrui Pharmaceuticals Co., Ltd. is a pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative medicines. Its current portfolio spans oncology, cardiovascular and metabolic diseases, aut..
>Volltext.. |
| 39511.96 Mio. EUR |
| 34651.7 Mio. EUR |
| 3897.49 Mio. EUR |
| 1060.03 Mio. EUR |
| 964.86 Mio. EUR |
| - |
| 93.18 Mio. EUR |
| 4987.78 Mio. EUR |
| 1115.79 Mio. EUR |
| 9.15 |
| 11% |
| 12.71% |
| 0.02 EUR |
| 0.46% |
| 0.47% |
| 29.04.26 - 0.02494872€ |
| - |
| HENGRUI |
| 24.09.26 |
|
||||
|